Pacira Biosciences (PCRX) said Monday it named Shawn Cross chief financial officer, starting immediately.
The company said Lauren Riker, who had been serving as its interim CFO since Oct. 1, will continue to serve as its senior vice president of finance.
Cross served as chief executive of Applied Molecular Transport from March 2023 until it was acquired by Cyclo Therapeutics (CYTH) in December 2023, Pacira said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments